Dr. Howard Chertkow

Director, Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, McGill University, Professor of Neurology, McGill University

Howard Chertkow is a cognitive neurologist, founder (with Howard Bergman) and director of the JGH/ McGill Memory Clinic. Dr. Chertkow is a member of the Jewish General Hospital’s Dept. of Clinical Neuroscience and Division of Geriatric Medicine. Dr. Chertkow’s major areas of research interest include 1) Early diagnosis of Alzheimer’s Disease and prediction of deterioration in individuals with Mild Cognitive Impairment. 2) the structure, organization, and function of the Semantic Memory component of long term memory, and its deterioration in dementia , 3) localization of language and memory functions in the brain using functional imaging. He has been continuously funded by the CIHR (Canadian Institutes for Health Research) and its forerunner, the MRC, for the past 23 years, and currently holds a CIHR grant to explore the natural history of Mild Cognitive Impairment and the neural substrate of semantic memory. He is co-applicant on grants to explore normal cognitive aging, MRI biomarkers for early dementia diagnosis, and microRNA blood measures for early dementia diagnosis. His CV lists 270 publications, including  150 peer-reviewed articles and chapters.  Twelve of his publications have over 100 citations, and three of the publications have been cited over 1000 times. In 2005 his team published the Montreal Cognitive Assessment (MoCA), which has become an international standard for diagnosis of MCI, and has been cited over 2000 times. Dr. Chertkow’s salary support has included a prestigious “Chercheur national” award from the FRSQ. Dr. Chertkow is past president of the Consortium of Canadian Centres for Clinical Cognitive Research (C5R). He was previously coordinator of the cognition axis of the provincial FRSQ network on Aging. In 2006 he chaired the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, which brought together many of the country’s experts to formulate new guidelines for physicians. Results have been published nationally and internationally.  In 2008 Dr. Chertkow received the national Irma Parhad Award from C5R for contributions to excellence in Alzheimer’s Disease research. In 2011 Dr. Chertkow was the only Canadian member of the NIH team which revised the diagnostic criteria for Alzheimer’s Disease (McKhann,  Knopman, Chertkow et al, 2011). Dr. Chertkow represents the Canadian Institutes of Health Research on the executive board of ADNI, the Alzheimer’s Disease Neuroimaging Initiative. He was also elected b his international peers to serve on the governing board of ISTAART, the International Alzheimer’s Association’s “ International Society to Advance Alzheimer’s Research and Treatment”.  Dr. Chertkow is the new Scientific Director for the Canadian Consortium for Neurodegeneration and Aging being establihed by the CIHR in 2014.

 

Dr. Howard Chertkow Grants